US HB1873 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 12 2021 - 25% progression, died in committee
Action: 2021-03-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 12 2021 - 25% progression, died in committee
Action: 2021-03-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To educate health care providers and the public on biosimilar biological products, and for other purposes.
Title
Advancing Education on Biosimilars Act of 2021
Sponsors
| Rep. Larry Bucshon [R-IN] | Rep. Scott Peters [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-03-16 | House | Referred to the Subcommittee on Health. |
| 2021-03-12 | House | Referred to the House Committee on Energy and Commerce. |
| 2021-03-12 | House | Introduced in House |
Same As/Similar To
HB19 (Related) 2021-10-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB164 (Same As) 2021-04-23 - Became Public Law No: 117-8.
SB164 (Same As) 2021-04-23 - Became Public Law No: 117-8.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/1873/all-info |
| Text | https://www.congress.gov/117/bills/hr1873/BILLS-117hr1873ih.pdf |
